COCP News and Press, Cocrystal Pharma Inc. From 08/19/21

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 19, 2021 – With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated, the need for rapid tes...

Influenza program Phase 1 clinical trial with CC-42344 on track to begin in the third quarter of 2021 COVID-19 program preclinical development with the novel oral SARS-CoV-2 protease inhibitors is advancing Two IND-enabling studies in the COVID-19 program expected to begin i...

New York, NY – August 03, 2021 – New COVID-19 cases continue to surge throughout the United States, causing municipal governments to spring into action to combat the rising number of the highly infectious Delta variant cases. On Monday, California and New York City announced...

Pinterest (NYSE:PINS) -20% on Q2 earnings release Cassava Sciences (NASDAQ:SAVA) -17% despite presenting 'positive' data on simufilam for Alzheimer's 360 DigiTech (NASDAQ:QFIN) -12%. Annovis Bio (NYSE:ANVS) -11%. Uxin (NASDAQ:UXIN) -11% on Q4 earnings release. Le...

CDI-45205 Shows Efficacy Against Delta Variant Cocrystal announced that its protease inhibitor against the COVID-19 virus, CDI-45205, showed potent in vitro activity against all four major variants. These include the Delta (India or B.1.617.2), Alpha (UK or B.1.1.7), Beta (South African or B.1...

Gainers: Intec Pharma (NASDAQ:NTEC) +61%. LendingClub Corporation (NYSE:LC) +55%. NanoVibronix (NASDAQ:NAOV) +36%. Golden Star Resources (NYSE:GSS) +28%. Dream Finders Homes (NASDAQ:DFH) +17%. E-Home Household Service Holdings (NASDAQ:EJH) +17%. Tempur Sealy International (NYSE:TPX) +16%. Hut...

Gainers: NanoVibronix (NASDAQ:NAOV) +49%, Intec Pharma (NASDAQ:NTEC) +31%, Cocrystal Pharma (NASDAQ:COCP) +17%, Burning Rock Biotech (NASDAQ:BNR) +11%, Genetron (NASDAQ:GTH) +8%. Losers: Annovis Bio (NYSE:ANVS) -48%, Atreca (NASDAQ:BCEL) -35%,...

LendingClub LC +38% on Q2 earnings. Cocrystal Pharma (NASDAQ:COCP) +26% SARS-CoV-2 3CL protease lead CDI-45205 demonstrates Broad-Spectrum activity against the SARS-CoV-2 Delta and Gamma Variants Flora Growth (NASDAQ:FLGC) +20%. Acer Therapeutics (NASDAQ:ACER) +21%. NanoVibroni...

Cocrystal Pharma (NASDAQ:COCP) soars 24.6% premarket after announcing that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2 Delta (India/B.1.617.2) and Gamma (Brazil/P.1) variants. The company previously reported t...

BOTHELL, Wash., July 29, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2...